---
title: "Insmed Insider Sold Shares Worth $640,708, According to a Recent SEC Filing"
date: "2025-02-08 06:22:18"
summary: "John Drayton Wise, Chief Commercial Officer, on February 05, 2025, sold 7,920 shares in Insmed  for $640,708. Following the Form 4 filing with the SEC, Wise has control over a total of 133,015 common shares of the company, with 133,015 shares held directly. SEC Filing:www.sec.gov/Archives/edgar/data/1104506/000162828025004460/xslF345X05/wk-form4_1738966262.xml"
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

John Drayton Wise, Chief Commercial Officer, on February 05, 2025, sold 7,920 shares in Insmed for $640,708. Following the Form 4 filing with the SEC, Wise has control over a total of 133,015 common shares of the company, with 133,015 shares held directly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/1104506/000162828025004460/xslF345X05/wk-form4\_1738966262.xml](https://www.sec.gov/Archives/edgar/data/1104506/000162828025004460/xslF345X05/wk-form4_1738966262.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313095:0/)
